Clik here to view.
Otsuka and Teva Sign Licensing Agreement for Japan on Prophylactic Migraine...
TOKYO & JERUSALEM Otsuka Pharmaceutical Co., Ltd (Otsuka) and Teva Pharmaceutical Industries, Ltd. (Teva) announce an agreement covering Japan for Otsuka to develop and commercialize Teva’s...
View ArticleClik here to view.
Taro to Announce Results for Year Ended March 31, 2017 on May 22, 2017
HAWTHORNE, N.Y. Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release its financial results for the fiscal year ended March 31, 2017, on Monday, May 22, 2017. The...
View ArticleClik here to view.
治験・臨床研究のペーパーレス化とコスト削減を実現する文書管理クラウドサービス「Agatha（アガサ）」が5月16日からアメリカ、ヨーロッパ、アジアへ提供開始
東京 （ビジネスワイヤ） — 医療・医薬分野向けクラウドサービス「Agatha（アガサ）」が日本国内での多くの導入・活用実績をふまえて海外マーケットへ本格進出します。6月18日（日）～22日（木）にアメリカ・イリノイ州シカゴで開催される「DIA（Drug Information Association）」の DIA Annual Meeting 2017（DIA...
View ArticleClik here to view.
Agatha’s Content Management Cloud for Life-Sciences and Healthcare...
TOKYO Agatha Inc. today announced the acceleration of the global expansion of Agatha’s Quality and Content Management Cloud Service for the Life-sciences and Healthcare (http://agathalife.com)....
View ArticleClik here to view.
Boehringer Ingelheim Inaugurates World-Class Biopharmaceutical Manufacturing...
INGELHEIM, Germany & SHANGHAI Today, Boehringer Ingelheim inaugurated its commercial production site for biopharmaceuticals in Zhang Jiang Hi-tech Park of Shanghai (China). The site, with the...
View ArticleClik here to view.
Agatha的生命科学和医疗保健内容管理云服务加快全球扩张的步伐
东京 (美国商业资讯) — Agatha Inc.今天宣布加快其生命科学和医疗保健品质及内容管理云服务(http://agathalife.com)的全球扩张。Agatha已在日本、欧洲和美国拥有成功的为客户服务的记录，现将进一步向全球市场进行扩张。Agatha将在6月18-22日于芝加哥召开的DIA 2017年会上呈报市面上最易于使用且最具成本效益的云服务。 易于使用、具成本效益且完全合规...
View ArticleClik here to view.
Boehringer Ingelheim strengthens early science portfolio through...
INGELHEIM, Germany & BEIJING, China Boehringer Ingelheim and Peking University (PKU) today announced an ambitious strategic partnership with the aim of jointly advancing early science innovation...
View ArticleClik here to view.
SERMO、史上初のグローバルな医師間医薬品評価ツールを発表
ニューヨーク （ビジネスワイヤ）– 世界各国で65万人の会員を持ち、医師向けのグローバルなソーシャルネットワークとして最大規模を誇るSERMO（サーモ）は本日、画期的な新しい「ドラッグ・レーティングス」（Drug...
View ArticleClik here to view.
CANbridge and AmoyDx Enter into Strategic Partnership for CAN008 Companion...
BEIJING CANbridge Life Sciences and Amoy Diagnostics announced that they have entered into a strategic partnership to develop a companion diagnostic assay for CANbridge’s lead candidate, CAN008, a...
View ArticleClik here to view.
Newron Pharmaceuticals Announces Expansion of STARS Study to Include Patients...
MILAN & MORRISTOWN, N.J. Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central...
View ArticleClik here to view.
Dr. Reddy’s Laboratories Announces USFDA Approval for the Launch of...
HYDERABAD, India & PRINCETON, N.J. Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that it has received approval from the U.S. Food and Drug Administration...
View ArticleClik here to view.
Sharklet Technologies Announces Acquisition by Peaceful Union and New...
AURORA, Colo. Sharklet Technologies, Inc., a biotechnology company lauded for the creation and commercialization of Sharklet®, the world’s first micro-texture that inhibits bacterial growth on...
View ArticleClik here to view.
GAMA Healthcare Ltd, World Leaders in Infection Control, Acquire Australian...
WATFORD, England Leading infection control specialists, GAMA Healthcare Ltd, acquires the Clinell division of their Australian distributor, AMCLA Pty Ltd., in Victoria. This significant investment...
View ArticleClik here to view.
GI Dynamics Announces EndoBarrier CE Mark Suspension
BOSTON & SYDNEY GI Dynamics®, Inc. (ASX:GID) today announced that it received notification from its notified body SGS United Kingdom Limited (SGS) that the CE Mark for its EndoBarrier® system...
View ArticleClik here to view.
Avita Medical Announces Positive Results from Pivotal Trial
VALENCIA, Calif. & PERTH, Australia Avita Medical Limited (ASX:AVH; OTCQX:AVMXY), a regenerative medicine company focused on the treatment of wounds and skin defects, today said it achieved both...
View ArticleClik here to view.
GI Dynamics Announces Access to 2017 Annual Meeting of Stockholders and...
BOSTON & SYDNEY GI Dynamics®, Inc. (ASX:GID) (the Company) will hold its 2017 Annual Meeting of Stockholders on 22 May 2017, at 6:00 p.m., United States Eastern Daylight Time, (23 May 2017, at...
View ArticleClik here to view.
Chi-Med Presents Clinical Data at ASCO 2017 Annual Meeting
LONDON Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) today announces that new clinical data on three of its novel tyrosine kinase inhibitors, fruquintinib, savolitinib and...
View ArticleClik here to view.
Company Profile for Laurus Labs Limited
Laurus is a leading research and development driven pharmaceutical company in India. The Company has grown consistently to become one of the leading manufacturers of Active Pharmaceutical...
View ArticleClik here to view.
Sharklet Technologies宣布被Peaceful Union收购，新的伙伴关系将加快应用Sharklet®的医疗器械及表面技术的开发
科罗拉多州奥罗拉 (美国商业资讯) — Sharklet Technologies, Inc.是一家生物技术公司，以发明和商业化Sharklet®而著称，Sharklet®是世界上首款微米织物，可抑制细菌在各类表面上的生长。该公司宣布已完成Peaceful Union领投的一次融资，Peaceful Union是中国杭州的一家医疗器械资产公司。该交易的条款未披露。...
View ArticleClik here to view.
Poxel Presents Imeglimin Japanese Phase 1 Results and Mechanistic Data at the...
LYON, France POXEL SA (Euronext – POXEL – FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes, announced...
View Article